- Report
- October 2022
- 270 Pages
Global
From €3367EUR$3,750USD£2,867GBP
- Report
- March 2024
- 221 Pages
Global
From €2200EUR$2,450USD£1,873GBP
- Report
- May 2022
- 196 Pages
Global
From €2357EUR$2,625USD£2,007GBP
€4714EUR$5,250USD£4,014GBP
- Report
- January 2024
- 150 Pages
Global
From €2918EUR$3,250USD£2,485GBP
€4355EUR$4,850USD£3,708GBP
- Report
- May 2024
- 134 Pages
Global
From €5835EUR$6,499USD£4,969GBP
- Report
- May 2024
- 134 Pages
Global
From €5835EUR$6,499USD£4,969GBP
- Report
- May 2024
- 170 Pages
Global
From €4040EUR$4,500USD£3,441GBP
- Report
- August 2022
- 118 Pages
Global
From €4040EUR$4,500USD£3,441GBP
- Report
- May 2024
- 160 Pages
Global
From €4443EUR$4,949USD£3,784GBP
- Report
- May 2024
- 200 Pages
Global
From €3726EUR$4,150USD£3,173GBP
- Report
- October 2023
- 145 Pages
Global
From €2828EUR$3,150USD£2,408GBP
- Report
- May 2023
- 160 Pages
Global
From €4443EUR$4,949USD£3,784GBP
- Report
- April 2023
- 180 Pages
Global
From €2694EUR$3,000USD£2,294GBP
- Report
- March 2023
- 30 Pages
Global
From €2918EUR$3,250USD£2,485GBP
- Report
- March 2023
- 30 Pages
Global
From €2918EUR$3,250USD£2,485GBP
- Report
- March 2024
- 150 Pages
Global
From €3995EUR$4,450USD£3,402GBP
- Report
- November 2022
- 191 Pages
From €3098EUR$3,450USD£2,638GBP
- Report
- November 2022
- 210 Pages
Asia Pacific
From €3098EUR$3,450USD£2,638GBP
- Report
- November 2022
- 222 Pages
Europe
From €3098EUR$3,450USD£2,638GBP
- Report
- November 2022
- 197 Pages
Africa, Middle East
From €3098EUR$3,450USD£2,638GBP

Interleukins are a group of cytokines, or proteins, that are involved in the regulation of the immune system. They are produced by a variety of cells, including T cells, B cells, and macrophages, and are involved in a wide range of biological processes, including inflammation, cell growth, and differentiation. Genomics has enabled researchers to better understand the role of interleukins in the immune system, and to develop new therapies for a variety of diseases.
In recent years, the interleukin market has grown significantly, with a number of companies developing new therapies and diagnostic tests. Companies such as AbbVie, Amgen, and Novartis are developing new interleukin-based therapies for a variety of diseases, while companies such as Genentech and Merck are developing diagnostic tests to detect interleukin levels in patients. Additionally, a number of biotechnology companies are developing new interleukin-based therapies for a variety of diseases. Show Less Read more